Hypertension Diagnostics, Inc.
HDIIOTCFinancial Services● Active
$0.00
+$0.00(+0.00%)
Market Cap$13681
P/E Ratio—
52W High$0.0002
52W Low$0.0001
Hypertension Diagnostics, Inc. (HDII) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HDII · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2021-12 | 2020-12 | 2019-12 | 2018-12 | 2017-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($0.00B) | $0.00B | $0.00B | ($0.00B) | $0.00B |
| Net Cash from Operations | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.00B) | ($0.00B) | ($0.00B) | $0.00B | $0.00B |
| Net Cash from Financing | $0.00B | $0.00B | ($0.00B) | $0.00B | $0.00B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) |
| FCF Margin %(computed) | — | — | — | -10.32% | -2.39% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Hypertension Diagnostics, Inc. data
About Hypertension Diagnostics, Inc. (HDII) Cash Flow Statement
Hypertension Diagnostics, Inc. generated operating cash flow of ($0.00B) and free cash flow of ($0.00B) for 2021 — a FCF margin of —. Capital expenditure was ($0.00B).
Frequently asked questions
HDII · 4 questionsHypertension Diagnostics, Inc. generated free cash flow of ($0.00B) for 2021, down 8011.4% year-over-year.
HDII free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10